Niagen Bioscience Ratios (2010-2026) | NAGE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	61.08%	61.12%	61.20%	61.02%	60.02%	59.82%	57.23%	59.93%	60.80%	61.40%	61.04%	60.74%	60.22%	63.49%	62.48%	63.42%	65.00%	64.52%	64.14%	63.47%
EBT Margin (Quarter)	-31.45%	-51.17%	-29.98%	-44.85%	-38.23%	-17.99%	-6.88%	-8.72%	-10.78%	-4.92%	0.54%	-2.22%	-0.07%	7.34%	25.70%	17.16%	12.01%	14.12%	13.07%	21.40%
EBIT Margin (Quarter)	-31.38%	-51.08%	-29.93%	-44.80%	-38.17%	-17.96%	-6.88%	-8.72%	-11.40%	-5.88%	-0.79%	-3.30%	-1.13%	6.26%	24.42%	15.66%	10.24%	12.46%	12.07%	5.01%
EBITDA Margin (Quarter)	-31.38%	-51.08%	-29.93%	-44.80%	-38.17%	-17.96%	-6.88%	-8.72%	-11.40%	-5.88%	-0.79%	-3.30%	-1.13%	6.26%	24.42%	15.66%	10.24%	12.46%	12.07%	5.01%
Operating Margin (Quarter)	-31.38%	-51.08%	-29.93%	-44.80%	-38.17%	-17.96%	-6.88%	-8.72%	-11.40%	-5.88%	-0.79%	-3.30%	-1.13%	6.26%	24.42%	15.66%	10.24%	12.46%	12.07%	5.01%
Net Margin (Quarter)	-31.45%	-51.17%	-29.98%	-44.85%	-38.23%	-17.99%	-6.88%	-8.72%	-10.78%	-4.92%	0.54%	-2.22%	-0.07%	7.34%	24.65%	16.61%	11.60%	13.47%	12.21%	20.07%
FCF Margin (Quarter)	-46.10%	-34.75%	-27.85%	-41.85%	-23.41%	-22.22%	-2.38%	11.97%	16.09%	1.90%	2.96%	1.15%	-1.21%	13.50%	29.23%	25.76%	3.48%	10.89%	1.71%	-3.99%
Efficiency
Inventory Average (Quarter)		12.43M	13.14M	14.45M	15.53M	15.69M	15.16M	13.29M	11.94M	12.30M	13.57M	13.51M	12.00M	11.03M	9.87M	10.19M	12.80M	16.60M	19.61M	22.22M
Assets Average (Quarter)		63.15M	59.15M	55.38M	49.77M	46.14M	49.86M	53.91M	53.47M	53.33M	54.22M	54.52M	54.06M	55.28M	62.40M	74.81M	86.43M	94.83M	102.27M	110.37M
Equity Average (Quarter)	42.99M	38.80M	33.59M	28.80M	23.33M	20.90M	24.85M	28.34M	27.58M	27.23M	27.88M	28.70M	29.83M	32.54M	40.23M	50.72M	59.77M	67.44M	73.60M	79.43M
Invested Capital (Quarter)	42.14M	35.45M	31.73M	25.88M	20.78M	21.02M	28.67M	28.02M	27.15M	27.31M	28.46M	28.95M	30.72M	34.37M	46.09M	55.34M	64.19M	70.68M	76.53M	82.33M
Asset Utilization Ratio (Quarter)		1.03	1.14	1.26	1.39	1.49	1.45	1.43	1.51	1.56	1.54	1.53	1.58	1.66	1.60	1.44	1.35	1.32	1.27	1.18
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-462.83	-589.40	-590.67	-966.50	-638.70	-613.00
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.64	0.59	0.55	0.49	0.45	0.46	0.53	0.52	0.51	0.51	0.52	0.54	0.57	0.61	0.68	0.68	0.70	0.72	0.72	0.72
Times Interest Earned (Quarter)	-462.83	-589.40	-590.67	-966.50	-638.70	-613.00
Valuation
Enterprise Value (Quarter)	-38.78M	-33.10M	-28.22M	-20.99M	-17.07M	-13.26M	-20.44M	-23.14M	-26.41M	-26.77M	-27.32M	-27.57M	-27.89M	-32.40M	-44.66M	-55.62M	-60.47M	-64.29M	-64.79M	-66.55M
Return Ratios
Return on Sales (Quarter)	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)		-61.35%	-65.18%	-74.79%	-88.23%	-76.50%	-58.23%	-36.25%	-25.55%	-20.29%	-16.66%	-12.44%	-6.36%	1.19%	17.38%	24.51%	26.00%	26.77%	19.77%	14.94%
Return on Invested Capital (Quarter)															0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)		0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Niagen Bioscience Ratios (2010-2026) | NAGE

Research Tools

Developers

Niagen Bioscience Ratios (2010-2026) | NAGE

Create an account

Sign In

Reset Password